Abbott’s Omacor Brings Omega-3s To Rx Drug Market As Adjunct Therapy
This article was originally published in The Tan Sheet
Executive Summary
Abbott Lab's prescription drug Omacor is the first omega-3 fatty acid product to gain FDA approval as a new molecular entity